Evestra Onkologia is a Polish biopharmaceutical start-up company that specializes in developing innovative oncology and antiproliferative assets. As a wholly-owned subsidiary of Evestra, Inc., a U. S.

-based biopharmaceutical company, Evestra Onkologia benefits from the expertise and resources of its parent company. With a focus on endometriosis, fibroids, and other proliferative diseases, the company aims to bring highly innovative oncology treatments to Poland and the EU. Evestra Onkologia collaborates with leading Polish research institutions, investigators, and for-profit CRO companies to enhance the development and commercialization of its assets.

The managing board, led by two seasoned executives in the pharmaceutical and life sciences industry, brings extensive experience in drug development. With a commitment to innovation and fruitful collaborations, Evestra Onkologia is dedicated to advancing oncology treatments and improving the lives of patients. Contact them today to learn more about their groundbreaking work